{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T03:31:27Z","timestamp":1794972687059,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["journals.elsevierhealth.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Nuclear Cardiology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.nuclcard.2024.102088","type":"journal-article","created":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T17:45:41Z","timestamp":1732383941000},"page":"102088","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Quantification of metabolic activity in the evaluation of cardiac sarcoidosis"],"prefix":"10.1016","volume":"43","author":[{"given":"Christiane","family":"Wiefels","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9449-9372","authenticated-orcid":false,"given":"Kevin","family":"Boczar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6495-1428","authenticated-orcid":false,"given":"David","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3811-8712","authenticated-orcid":false,"given":"Panithaya","family":"Chareonthaitawee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nuclcard.2024.102088_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.17996\/anc.17-00042","article-title":"New guidelines for diagnosis of cardiac sarcoidosis in Japan","volume":"3","author":"Terasaki","year":"2017","journal-title":"Ann Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.nuclcard.2024.102088_bib3","first-page":"19","article-title":"The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool","volume":"31","author":"Judson","year":"2014","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.nuclcard.2024.102088_bib4","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","article-title":"Challenges in cardiac and pulmonary sarcoidosis","volume":"76","author":"Trivieri","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib5","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/joim.13629","article-title":"Sarcoidosis: epidemiology and clinical insights","volume":"293","author":"Rossides","year":"2023","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.nuclcard.2024.102088_bib6","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.nuclcard.2024.102088_bib7","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","article-title":"Sarcoidosis","volume":"383","author":"Valeyre","year":"2014","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.nuclcard.2024.102088_bib8","first-page":"50","article-title":"Pulmonary sarcoidosis in the Nordic countries 1950-1982. Epidemiology and clinical picture","volume":"7","author":"Milman","year":"1990","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.nuclcard.2024.102088_bib9","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib10","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.jcmg.2017.07.005","article-title":"Maximizing the prognostic value of cardiac PET in patients with suspected cardiac sarcoidosis","volume":"11","author":"Blankstein","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib11","first-page":"89","article-title":"the Diffuse Pulmonary Study Group of the Health and Labor Sciences Research Grant-supported Rare\/Intractable Disease Project, et\u00a0al. The Committee for revision of the diagnostic standard for sarcoidosis. Diagnostic standard and guideline for sarcoidosis","volume":"27","year":"2007","journal-title":"Jpn J Sarcoidosis Granulomatous Disord."},{"key":"10.1016\/j.nuclcard.2024.102088_bib12","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.hrthm.2014.03.043","article-title":"HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis","volume":"11","author":"Birnie","year":"2014","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.nuclcard.2024.102088_bib13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.2967\/jnumed.117.196287","article-title":"Joint SNMMI-ASNC expert consensus document on the role of 18F-FDG PET\/CT in carDiac sarcoid detection and therapy monitoring writing group","volume":"58","author":"Chareonthaitawee","year":"2017","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102088_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/ehjci\/jex146","article-title":"A\u00a0joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and inflammation & infection committees of the European association of nuclear medicine, the European association of cardiovascular imaging, and the American","volume":"18","author":"Slart","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib15","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1161\/CIRCULATIONAHA.118.035032","article-title":"Improving the diagnostic performance of 18F-fluorodeoxyglucose positron-emission tomography\/computed tomography in prosthetic heart valve endocarditis","volume":"138","author":"Swart","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.nuclcard.2024.102088_bib16","first-page":"1989","article-title":"Usefulness of fasting 18 F-FDG PET in identification of cardiac sarcoidosis","volume":"45","author":"Okumura","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102088_bib17","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jcmg.2019.12.013","article-title":"Effect of corticosteroid dose and duration on 18-fluorodeoxyglucose positron emission tomography in cardiac sarcoidosis","volume":"13","author":"Okada","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12350-016-0682-1","article-title":"The role of serial FDG PET for assessing therapeutic response in patients with cardiac sarcoidosis","volume":"24","author":"Lee","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib19","first-page":"342","article-title":"Quantitative Interpretation of FDG PET for cardiac sarcoidosis reclassifies visually interpreted exams and potentially impacts downstream interventions","volume":"35","author":"Varghese","year":"2018","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.nuclcard.2024.102088_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12350-020-02201-5","article-title":"Quantitative assessment of cardiac hypermetabolism and perfusion for diagnosis of cardiac sarcoidosis","volume":"29","author":"Miller","year":"2022","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib21","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1007\/s12350-021-02886-2","article-title":"18F-FDG\/13N-ammonia cardiac PET findings in ATTR cardiac amyloidosis","volume":"30","author":"Young","year":"2023","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib22","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jcmg.2010.09.015","article-title":"Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis","volume":"3","author":"Tahara","year":"2010","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jcmg.2017.04.020","article-title":"Prognostic impact of extent, severity, and heterogeneity of abnormalities on 18F-FDG PET scans for suspected cardiac sarcoidosis","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib24","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/ehjci\/jex175","article-title":"Heterogeneity of myocardial 2-[18F]fluoro-2-deoxy-D-glucose uptake is a typical feature in cardiac sarcoidosis: a study of\u00a0231 patients","volume":"19","author":"Schildt","year":"2018","journal-title":"Eur Heart J - Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib26","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s12350-014-9901-9","article-title":"Quantitative interpretation of FDG PET\/CT with myocardial perfusion imaging increases diagnostic information in the evaluation of cardiac sarcoidosis","volume":"21","author":"Ahmadian","year":"2014","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib27","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1007\/s00259-018-4195-9","article-title":"Use of 18F-FDG PET\/CT texture analysis to diagnose cardiac sarcoidosis","volume":"46","author":"Manabe","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib28","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2967\/jnumed.113.129858","article-title":"Tumor texture analysis in 18 F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis","volume":"55","author":"Orlhac","year":"2014","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102088_bib30","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A\u00a0systematic review of the factors affecting accuracy\u00a0of\u00a0SUV measurements","volume":"195","author":"Adams","year":"2010","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0040-1712535","article-title":"Cardiac sarcoidosis","volume":"41","author":"Birnie","year":"2020","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.nuclcard.2024.102088_bib25","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCIMAGING.112.000289","article-title":"Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by 18 F- fluorodoexyglucose positron emission tomography?","volume":"6","author":"Mc Ardle","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib32","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1007\/s00259-013-2460-5","article-title":"Elevated 18F-fluorodeoxyglucose uptake in the interventricular septum is associated with atrioventricular block in patients with suspected cardiac involvement sarcoidosis","volume":"40","author":"Manabe","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib33","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.nuclcard.2024.102088_bib34","first-page":"1944","article-title":"Effect of immunosuppressive therapy and biopsy status in monitoring therapy response in suspected cardiac sarcoidosis","volume":"15","author":"Rojulpote","year":"2022","journal-title":"Cardiovascular Imaging"},{"key":"10.1016\/j.nuclcard.2024.102088_bib35","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s12350-016-0490-7","article-title":"The response of FDG uptake to immunosuppressive treatment on FDG PET\/CT imaging for cardiac sarcoidosis","volume":"24","author":"Ahmadian","year":"2017","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S0969-8051(00)00155-4","article-title":"Sung-cheng. Anatomy of SUV","volume":"27","author":"Huang","year":"2000","journal-title":"Nucl Med Biol"},{"key":"10.1016\/j.nuclcard.2024.102088_bib29","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Journal of Nuclear Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124007906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071358124007906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T10:48:34Z","timestamp":1737629314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071358124007906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"alternative-id":["S1071358124007906"],"URL":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102088","relation":{},"ISSN":["1071-3581"],"issn-type":[{"value":"1071-3581","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantification of metabolic activity in the evaluation of cardiac sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Nuclear Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nuclcard.2024.102088","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society of Nuclear Cardiology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102088"}}